Analyst Reco. Amgen Inc. Buenos Aires S.E.

Equities

AMGN

ARDEUT110665

End-of-day quote Buenos Aires S.E. Other stock markets 18:00:00 2024-06-13 EDT			5-day change	1st Jan Change
12,568 ^ARS	-1.15%		-5.90%	+34.65%

06-14	Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto	DJ
06-14	Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Raises Price Target on Amgen to $332 From $328, Maintains Outperform Rating	06-14	MT
RBC Raises Price Target on Amgen to $332 From $328, Maintains Outperform Rating	06-14	MT
HSBC Adjusts Price Target on Amgen to $356 From $322	05-20	MT
Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating	05-13	MT
ANALYST RECOMMENDATIONS : UBER, Luluemon, Airbnb, Progressive...	05-09
Redburn Atlantic Adjusts Price Target on Amgen to $180 From $170	05-09	MT
Mizuho Securities Raises Amgen's Price Target to $235 From $223	05-08	MT
North American Morning Briefing : Stock Futures -2-	05-06	DJ
UBS Adjusts Price Target on Amgen to $307 From $284, Maintains Neutral Rating	05-03	MT
Deutsche Bank Adjusts Price Target on Amgen to $310 From $285, Hold Rating Maintained	05-03	MT
William Blair Upgrades Amgen to Outperform From Market Perform	05-03	MT
Leerink Adjusts Price Target on Amgen to $352 From $324, Keeps Market Perform Rating	05-03	MT
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	05-03	RE
Barclays Upgrades Amgen to Equalweight From Underweight, Adjusts Price Target to $300 From $230	05-03	MT
Morgan Stanley Adjusts Price Target on Amgen to $310 From $271, Keeps Equalweight Rating	05-03	MT
RBC Adjusts Price Target on Amgen to $328 From $332, Keeps Outperform Rating	05-03	MT
BMO Capital Adjusts Price Target on Amgen to $355 From $336, Keeps Outperform Rating	05-03	MT
Goldman Sachs Adjusts Price Target on Amgen to $350 From $359, Keeps Buy Rating	05-03	MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	05-03
UBS Adjusts Amgen's Price Target to $284 From $314, Maintains Neutral Rating	04-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Amgen Inc. Buenos Aires S.E.

Equities

AMGN

ARDEUT110665

Analyst Reco.

Filters